Touchstone Innovations portfolio company IXICO, the brain health company, has announced that Giulio Cerroni will be appointed to the Board as Chief Executive Officer (CEO) with effect from 6 February 2017. Derek Hill, the co-founder and current CEO, will remain on the board and continue to serve the Company as an executive director.
Giulio has almost 30 years of international management experience gained in life sciences and diagnostics sectors. He was previously Managing Director of the Genomics division of LGC Group (LGC), the international life sciences measurement and testing company. At LGC, he grew divisional revenues threefold and doubled profits through a combined organic and acquisitive growth strategy into an organisation with 480 staff based in ten locations globally. Previously, Giulio held a variety of senior roles at Thermo Fisher Scientific, Abgene, Anachem, ICN Biomedicals and Du Pont. He has a BSc from Cardiff University and an MBA from Warwick Business School.
Giulio Cerroni commented:
“I am very excited to be joining IXICO to lead the Company's next stage of growth towards becoming the global leader in digital healthcare technologies for the brain health market. Brain diseases are an area of huge unmet need and provide a significant growth opportunity for IXICO's digital health technology platform. In particular, I believe that our scientific leadership in medical data analysis makes IXICO uniquely placed to become the global partner of choice to the pharmaceutical industry as they integrate digital healthcare technologies as part of their overall product offering.”